Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD
Clinical trial NCT02298283 · COMPLETED
Trial details
- NCT number
- NCT02298283
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2020-07-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.